Tirzepatide in Los Angeles (2026)

The best ways to get Tirzepatide in Los Angeles, California. Compare 205 providers, compounded vs brand pricing, and local insurance.

205 Tirzepatide providersCompounded from $119/moAvg ~$2,472/yr less than Zepbound self-pay

Featured Partners · Los Angeles

Featured Tirzepatide providers serving Los Angeles

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

  1. Top pick
    7.7

    Compounded tirzepatide from

    See pricing

    Get started →
  2. Compounded tirzepatide from

    $129/mo

    “starting at” price

    Get started →
  3. Compounded tirzepatide from

    $129/mo

    sale price

    Get started →
  4. 8.2

    Compounded tirzepatide from

    $179/mo

    prepaid plan rate

    Get started →
  5. Compounded tirzepatide from

    $239/mo

    12-month plan rate

    Get started →
  6. 8.1

    Compounded tirzepatide from

    $250/mo

    starting dose

    Get started →
Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Getting Tirzepatide in Los Angeles

Los Angeles is the second-largest city in the United States, located in California with a population of approximately 4.0 million. Telehealth is legal in California, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Los Angeles ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

Los Angeles residents have access to both brand-name Tirzepatide (Zepbound and Mounjaro) and compounded Tirzepatide formulations through licensed 503A compounding pharmacies[4]. Brand-name Zepbound costs $449/month through the manufacturer's self-pay program (LillyDirect self-pay, 7.5–15 mg; list price $1,086)[3], while compounded Tirzepatide from telehealth providers averages around $243/month (ongoing rate) in California[1] — about $2,472 a year less than self-pay Zepbound. Insurance coverage for anti-obesity GLP-1s in California varies by plan[5], and California's adult obesity rate is approximately 26.2%[2].

For the full step-by-step process, read our how to get tirzepatide online guide. To compare every low-cost route, see our cheapest way to get GLP-1s without insurance guide. If you're weighing compounded against brand-name tirzepatide, our compounded vs. branded GLP-1 decision guide breaks down the evidence. Before starting, review what the clinical trials actually showed about GLP-1 side effects.

Brand Zepbound
LillyDirect self-pay, 7.5–15 mg (list $1,086)
$449/mo
Compounded Tirzepatide
California average, ongoing rate
$243/mo
Annual savings
average vs Zepbound self-pay
$2,472

Tirzepatide in Los Angeles: The California Numbers

Our clinic directory lists 283 weight-management/obesity-medicine clinics in Los Angeles (201 with a public profile) — an in-person option alongside the telehealth providers above. Among the Tirzepatide providers above serving California, ongoing pricing ranges from $119 to $1688/mo. The cheapest verified ongoing compounded Tirzepatide price available to Los Angeles residents is $119/mo — verified against the provider's live pricing, not an advertised teaser. On the insured side, California Medicaid reimbursed approximately $192,263,663 across 179,436 Tirzepatide-class prescriptions in Q1 2026 (all covered indications, gross before rebates — full state series).

Local clinics with a public profile: Mariola Ficinski, Mitchell Cohen, Vivien Bonert, Glenn Braunstein, The Regents of the University of California and 196 more.

All Tirzepatide Providers Serving Los Angeles

8.1/ 10
Partner

bmiMD

Best for: one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan

★★★★☆4.1/5

Editorial score · methodology

$159/mosemaglutide
$249/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
8.1/ 10
Partner

RxSpan MD

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

★★★★☆4.1/5

Editorial score · methodology

$249/mosemaglutide
$329/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full RxSpan MD review →
8.0/ 10
Partner

Strut Health

Best for: oral-lozenge compounded GLP-1 access

★★★★☆4/5

Editorial score · methodology

$99/mosemaglutide
“starting at” price
$149/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Strut Health review →
7.9/ 10
Partner

GobyMeds

Best for: no-membership, no-auto-renew compounded GLP-1 orders, from about $99/mo on a 3-month bundle

★★★★☆4/5

Editorial score · methodology

$169/mosemaglutide
“starting at” price
$299/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full GobyMeds review →
7.7/ 10
Partner

Live Vital

Best for: low-cost, physician-led compounded GLP-1 with peptide and hormone options

★★★★☆3.9/5

Editorial score · methodology

$130/mosemaglutide
after intro offer
$239/motirzepatide
after intro offer
CompoundedSemaglutideTirzepatideBPC-157CJC-1295 / Ipamorelin
Get StartedRead full Live Vital review →
Browse all 205 Tirzepatide providers serving Los Angeles A–Z

Tirzepatide in Los Angeles and the rest of California

Los Angeles is the largest of the 18 California cities we cover, and the 205 tirzepatide programs listed here are licensed statewide, so nothing on this page is priced differently a county over. For the state-level price range, see tirzepatide across California. Compounded tirzepatide starts at $119/mo for California addresses; semaglutide in Los Angeles starts lower, at $87/mo.

Medicaid in California ended its weight-loss coverage of GLP-1s, though it still covers Zepbound for sleep apnea with prior authorization. It does cover GLP-1s for type 2 diabetes. Our California Medicaid GLP-1 coverage guide has the current criteria and the appeal process. Elsewhere in California, we publish the same breakdown for tirzepatide in San Diego and tirzepatide in San Jose.

Related Pages

Frequently Asked Questions

Los Angeles residents can get Tirzepatide through licensed telehealth providers that ship directly to California addresses. Brand-name Zepbound and Mounjaro can also be prescribed in-person by a local clinician and filled at a retail pharmacy; the manufacturer's own self-pay price is $449/mo (LillyDirect self-pay, 7.5–15 mg), against a list price of $1,086/mo.
Compounded Tirzepatide pricing is set at the provider level, not the city level. See the provider cards above for current monthly pricing from providers that serve California. Brand-name Zepbound costs $449/month through the manufacturer's self-pay program (list price $1,086).
Yes. Compounded Tirzepatide is legal in California when prescribed by a licensed provider and dispensed by a 503A or 503B compounding pharmacy. Los Angeles residents can legally receive shipments from licensed compounders located in any US state.
Insurance coverage in Los Angeles for Tirzepatide depends on your diagnosis and plan. Most insurers cover the diabetes-indicated brands (Mounjaro) for type 2 diabetes, but coverage for the obesity-indicated brands (Zepbound) is much more limited and typically requires prior authorization.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Get Tirzepatide Price Alerts in Los Angeles

Be the first to know about new Tirzepatide promos and providers in Los Angeles.

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
  3. 3.LillyDirect — Zepbound self-pay program and cash price— Eli Lilly and Company (LillyDirect).
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.